Acknowledgement
The authors thank Prof. Hyeon Chang Kim (Department of Preventive Medicine, Yonsei University College of Medicine) for reviewing the manuscript and Medical Illustration & Design Team for providing excellent support with medical illustrations.
References
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49. https://doi.org/10.3322/caac.21660
- Edgren G, Adami HO, Weiderpass E, Nyren O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut 2013;62:1406-14. https://doi.org/10.1136/gutjnl-2012-302412
- Hong S, Won YJ, Park YR, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer Res Treat 2020;52:335-50. https://doi.org/10.4143/crt.2020.206
- Shin A, Won YJ, Jung HK, et al. Trends in incidence and survival of esophageal cancer in Korea: analysis of the Korea Central Cancer Registry Database. J Gastroenterol Hepatol 2018;33:1961-8. https://doi.org/10.1111/jgh.14289
- Kim JJ. Epidemiology of gastroesophageal junction adenocarcinoma in Korea. J Gastric Cancer 2018;18:328-38. https://doi.org/10.5230/jgc.2018.18.e38
- Yang S, Lin S, Li N, et al. Burden, trends, and risk factors of esophageal cancer in China from 1990 to 2017: an up-to-date overview and comparison with those in Japan and South Korea. J Hematol Oncol 2020;13:146. https://doi.org/10.1186/s13045-020-00981-4
- Jung HK, Tae CH, Lee HA, et al. Treatment pattern and overall survival in esophageal cancer during a 13-year period: a nationwide cohort study of 6,354 Korean patients. PLoS One 2020;15:e0231456. https://doi.org/10.1371/journal.pone.0231456
- Sawas T, Killcoyne S, Iyer PG, et al. Identification of prognostic phenotypes of esophageal adenocarcinoma in 2 independent cohorts. Gastroenterology 2018;155:1720-8. https://doi.org/10.1053/j.gastro.2018.08.036